Abbott Laboratories Stock Today
| ABT Stock | USD 124.54 0.66 0.53% |
PerformanceWeakest
| Odds Of DistressLow
|
Abbott Laboratories is selling for under 124.54 as of the 24th of December 2025; that is 0.53 percent down since the beginning of the trading day. The stock's last reported lowest price was 123.85. Abbott Laboratories has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on December 12, 2025, Representative Julie Johnson of US Congress acquired under $15k worth of Abbott Laboratories's common stock.
Business Domain Health Care Equipment & Services | IPO Date 13th of January 1978 | Category Healthcare | Classification Health Care |
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 1.74 B outstanding shares of which 18.49 M shares are presently shorted by investors with about 2.86 days to cover. More on Abbott Laboratories
Moving together with Abbott Stock
Moving against Abbott Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Abbott Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | Robert Ford | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [Absolute Software Corporation, Abbott Laboratories, Aqua Bio Technology ASA, Abundant Produce Limited, Abbott Laboratories] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, VN Index, NYSE 100 Index, SP 500 Index, VN Small Cap, BETTERINVESTING 100 INDEX, SP 100 Index, ARCA Institutional, BTRINVSTNG 100 INDEX, VN All Shares, SP 100, Obamacare Repeal, Compulsion, SRI Sustainable Growth, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excise Tax Activities | Animal TestingCatholic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAbbott Laboratories can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Abbott Laboratories' financial leverage. It provides some insight into what part of Abbott Laboratories' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbott Laboratories (ABT) is traded on New York Stock Exchange in USA and employs 114,000 people. Abbott Laboratories is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 217.91 B. Abbott Laboratories runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 1.74 B outstanding shares of which 18.49 M shares are presently shorted by investors with about 2.86 days to cover.
Abbott Laboratories has about 7.62 B in cash with 8.56 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.68.
Check Abbott Laboratories Probability Of Bankruptcy
Ownership AllocationAbbott Laboratories holds a total of 1.74 Billion outstanding shares. The majority of Abbott Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Abbott Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Abbott Laboratories. Please pay attention to any change in the institutional holdings of Abbott Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that on December 12, 2025, Representative Julie Johnson of US Congress acquired under $15k worth of Abbott Laboratories's common stock.
Check Abbott Ownership Details
Abbott Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Northern Trust Corp | 2025-06-30 | 21 M | |
| Wells Fargo & Co | 2025-06-30 | 17.2 M | |
| Goldman Sachs Group Inc | 2025-06-30 | 15.2 M | |
| Massachusetts Financial Services Company | 2025-06-30 | 14.3 M | |
| State Farm Mutual Automobile Ins Co | 2025-06-30 | 13.6 M | |
| Fmr Inc | 2025-06-30 | 13.6 M | |
| Charles Schwab Investment Management Inc | 2025-06-30 | 13.2 M | |
| Ameriprise Financial Inc | 2025-06-30 | 13 M | |
| Ubs Asset Mgmt Americas Inc | 2025-06-30 | 12.7 M | |
| Vanguard Group Inc | 2025-06-30 | 172.8 M | |
| Blackrock Inc | 2025-06-30 | 141.3 M |
Abbott Laboratories Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Abbott Laboratories market risk premium is the additional return an investor will receive from holding Abbott Laboratories long position in a well-diversified portfolio.
| Mean Deviation | 0.8733 | |||
| Standard Deviation | 1.13 | |||
| Variance | 1.27 | |||
| Risk Adjusted Performance | (0.07) |
Abbott Stock Against Markets
Abbott Laboratories Corporate Directors
| Samuel Scott | Independent Director | Profile | |
| Phebe Novakovic | Independent Director | Profile | |
| Roxanne Austin | Independent Director | Profile | |
| Sally Blount | Independent Director | Profile |
Already Invested in Abbott Laboratories?
The danger of trading Abbott Laboratories is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Abbott Laboratories is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Abbott Laboratories. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Abbott Laboratories is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.